Cargando…

Ras Mitogen-activated Protein Kinase Signaling and Kinase Suppressor of Ras as Therapeutic Targets for Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is a high incidence cancer and a major health concern worldwide. Among the many molecular signaling pathways that are dysregulated in HCC, the Ras mitogen-activated protein kinase (Ras/Raf/MAPK) signaling pathway has gained renewed attention from basic and clinical res...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moon, Hyuk, Ro, Simon Weonsang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Liver Cancer Association 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035721/ https://www.ncbi.nlm.nih.gov/pubmed/37384270 http://dx.doi.org/10.17998/jlc.21.1.1

Ejemplares similares

The Kinase Activity-deficient Isoform of the Protein Araf Antagonizes Ras/Mitogen-activated Protein Kinase (Ras/MAPK) Signaling in the Zebrafish Embryo
por: Xiong, Cong, et al.
Publicado: (2015)

The RAS/mitogen activated protein (MAP) kinase pathway in melanoma biology and therapeutics
por: Jarell, Abel D, et al.
Publicado: (2007)

Target Therapy for Hepatocellular Carcinoma: Beyond Receptor Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors
por: Park, Hyunjung, et al.
Publicado: (2022)

MAPK/ERK Signaling Pathway in Hepatocellular Carcinoma
por: Moon, Hyuk, et al.
Publicado: (2021)

Arresting kinase suppressor of Ras in an inactive state
por: Badshah, Syed Lal, et al.
Publicado: (2017)

Coordinating ERK signaling via the molecular scaffold Kinase Suppressor of Ras
por: Frodyma, Danielle, et al.
Publicado: (2017)

The regulation of oncogenic Ras/ERK signalling by dual-specificity mitogen activated protein kinase phosphatases (MKPs)
por: Kidger, Andrew M., et al.
Publicado: (2016)

Exploring the Molecular Landscape of Myelofibrosis, with a Focus on Ras and Mitogen-Activated Protein (MAP) Kinase Signaling
por: Reynolds, Samuel B., et al.
Publicado: (2023)

Exploring the JAK/STAT Signaling Pathway in Hepatocellular Carcinoma: Unraveling Signaling Complexity and Therapeutic Implications
por: Park, Hyunjung, et al.
Publicado: (2023)

ERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentially
por: Vantaggiato, Chiara, et al.
Publicado: (2006)

Targeting EGFR/PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma
por: Bang, Jieun, et al.
Publicado: (2023)

Aurora kinase A interacts with H-Ras and potentiates Ras-MAPK signaling
por: Umstead, MaKendra, et al.
Publicado: (2017)

Comparison of liver oncogenic potential among human RAS isoforms
por: Chung, Sook In, et al.
Publicado: (2016)

RAS–Mitogen-Activated Protein Kinase Signal Is Required for Enhanced PD-L1 Expression in Human Lung Cancers
por: Sumimoto, Hidetoshi, et al.
Publicado: (2016)

Kinase Suppressor of Ras 1 Is Not Required for the Generation of Regulatory and Memory T Cells
por: Le Borgne, Marie, et al.
Publicado: (2013)

Identification of a truncated kinase suppressor of Ras 2 mRNA in sperm
por: Guo, Lili, et al.
Publicado: (2014)

Obesity‐dependent dysregulation of glucose homeostasis in kinase suppressor of ras 2(−/−) mice
por: Henry, MaLinda D., et al.
Publicado: (2014)

WDR76 is a RAS binding protein that functions as a tumor suppressor via RAS degradation
por: Jeong, Woo-Jeong, et al.
Publicado: (2019)

The NF2 tumor suppressor merlin interacts with Ras and RasGAP, which may modulate Ras signaling
por: Cui, Yan, et al.
Publicado: (2019)

Kinase-mediated RAS signaling via membraneless cytoplasmic protein granules
por: Tulpule, Asmin, et al.
Publicado: (2021)

IQ Motif Containing GTPase Activating Proteins (IQGAPs), A-Kinase Anchoring Proteins (AKAPs) and Kinase Suppressor of Ras Proteins (KSRs) in Scaffolding Oncogenic Pathways and Their Therapeutic Potential
por: Mohapatra, Talina, et al.
Publicado: (2022)

Contribution of Somatic Ras/Raf/Mitogen-Activated Protein Kinase Variants in the Hippocampus in Drug-Resistant Mesial Temporal Lobe Epilepsy
por: Khoshkhoo, Sattar, et al.
Publicado: (2023)

Epigenetic identification of mitogen-activated protein kinase 10 as a functional tumor suppressor and clinical significance for hepatocellular carcinoma
por: Tang, Liping, et al.
Publicado: (2021)

Selective Regulation of B-Raf Dependent K-Ras/Mitogen-Activated Protein by Natural Occurring Multi-kinase Inhibitors in Cancer Cells
por: Abd El Maksoud, Ahmed I., et al.
Publicado: (2019)

Altered canonical and striatal-frontal resting state functional connectivity in children with pathogenic variants in the Ras/mitogen-activated protein kinase pathway
por: Bruno, Jennifer L., et al.
Publicado: (2022)

Dynamic regulation of RAS and RAS signaling
por: Kolch, Walter, et al.
Publicado: (2023)

Kinase Suppressor of Ras 2 (KSR2) expression in the brain regulates energy balance and glucose homeostasis
por: Guo, Lili, et al.
Publicado: (2016)

Ras-Related C3 Botulinum Toxin Substrate 1 Combining With the Mixed Lineage Kinase 3- Mitogen-Activated Protein Kinase 7- c-Jun N-Terminal Kinase Signaling Module Accelerates Diabetic Nephropathy
por: Ying, Changjiang, et al.
Publicado: (2021)

High Risk of Hepatocellular Carcinoma Development in Fibrotic Liver: Role of the Hippo-YAP/TAZ Signaling Pathway
por: Moon, Hyuk, et al.
Publicado: (2019)

Dual Stimulation of Ras/Mitogen-Activated Protein Kinase and Rhoa by Cell Adhesion to Fibronectin Supports Growth Factor–Stimulated Cell Cycle Progression
por: Danen, Erik H.J., et al.
Publicado: (2000)

Oncogenic K-Ras and Basic Fibroblast Growth Factor Prevent FAS-Mediated Apoptosis in Fibroblasts through Activation of Mitogen-Activated Protein Kinase
por: Kazama, Hirotaka, et al.
Publicado: (2000)

Interaction between the bone morphogenetic proteins and Ras/MAP-kinase signalling pathways in lung cancer
por: Kraunz, K S, et al.
Publicado: (2005)

Reversing multidrug resistance in hepatocellular carcinoma cells by inhibiting extracellular signal-regulated kinase/mitogen-activated protein kinase signaling pathway activity
por: CHEN, SIYUAN, et al.
Publicado: (2014)

Activated Ras as a Therapeutic Target: Constraints on Directly Targeting Ras Isoforms and Wild-Type versus Mutated Proteins
por: Mattingly, Raymond R.
Publicado: (2013)

P62(dok), a Negative Regulator of Ras and Mitogen-Activated Protein Kinase (Mapk) Activity, Opposes Leukemogenesis by P210(bcr-abl)
por: Di Cristofano, Antonio, et al.
Publicado: (2001)

Targeting cysteine rich C1 domain of Scaffold protein Kinase Suppressor of Ras (KSR) with anthocyanidins and flavonoids – a binding affinity characterization study
por: Karthik, Dhananjayan, et al.
Publicado: (2014)

Kinase suppressor of Ras 1 and Exo70 promote fatty acid-stimulated neurotensin secretion through ERK1/2 signaling
por: Rock, Stephanie, et al.
Publicado: (2019)

Oncogene Ras/Phosphatidylinositol 3-Kinase Signaling Targets Histone H3 Acetylation at Lysine 56
por: Liu, Yan, et al.
Publicado: (2012)

Targeting Ras with protein engineering
por: Tomazini, Atilio, et al.
Publicado: (2023)

Is Mitogen‐Activated Protein Kinase Phosphatase 5 a Solution to the Puzzle of the Mitogen‐Activated Protein Kinase Signal in Steatohepatitis?
por: Miura, Kouichi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ub1krl57khb1a2k7rcmkkffuck